Medi-Ject recalls insulin injector after FDA warning:
This article was originally published in Clinica
Executive Summary
Medi-Ject has made a voluntary recall of its Choice needle-less insulin delivery system following an FDA warning letter to the company in August over poor procedures in place to handle customer complaints. A small number of device failures had occurred and the FDA found poor procedures at the company for recording and investigating them.